Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Glaucoma | Research article

OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy

Authors: Hannah Weindler, Martin S. Spitzer, Maximilian Schultheiß, Robert Kromer

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Primary open-angle glaucoma (POAG) is a progressive neurodegenerative disease which leads to irreversible blindness. An elevated intraocular pressure (IOP) is considered to be the main risk factor for the disease progression. It is known that retinal blood flow is altered in POAG eyes. Tafluprost, a prostaglandin analogue which lowers the IOP, has shown to also improve the retinal blood flow in animals.

Methods

The current study therefore evaluated the retinal vessel density in the peripapillary and macular region of POAG patients with normal IOP treated with topical Tafluprost (n = 20) compared to surgically treated patients with normal IOP (n = 22) using optical coherence tomography angiography (OCT-A). The retinal flow density was obtained after binarisation and evaluated in five sectors.

Results

There was a significantly higher peripapillary flow density in all sectors in Tafluprost treated eyes when compared to post-surgery eyes. The flow density in the inferior sector of the superficial plexus in the macular region was also significantly higher in the Tafluprost group.
Conclusions: These results indicate that Tafluprost not only lowers IOP, but may also enhance retinal blood flow in POAG patients with a normal IOP.
Literature
1.
2.
3.
4.
Triolo G, Rabiolo A, Shemonski ND, Fard A, Di Matteo F, Sacconi R, et al. Optical coherence tomography angiography macular and Peripapillary vessel perfusion density in healthy subjects, glaucoma suspects, and glaucoma patients. Invest Ophthalmol Vis Sci. 2017;58(13):5713–22.PubMedCrossRef
5.
Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52(Suppl 2):S162–73.PubMedCrossRef
6.
Izumi N, Nagaoka T, Sato E, Mori F, Takahashi A, Sogawa K, et al. Short-term effects of topical tafluprost on retinal blood flow in cats. J Ocul Pharmacol Ther. 2008;24(5):521–6.PubMedCrossRef
7.
Mayama C, Ishii K, Saeki T, Ota T, Tomidokoro A, Araie M. Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma. Invest Ophthalmol Vis Sci. 2010;51(8):4117–24.PubMedCrossRef
8.
Aizawa N, Kunikata H, Shiga Y, Tsuda S, Yokoyama Y, Omodaka K, et al. Preperimetric glaucoma prospective observational study (PPGPS): design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye. PLoS One. 2017;12(12):e0188692.PubMedPubMedCentralCrossRef
9.
Iida Y, Akagi T, Nakanishi H, Ohashi Ikeda H, Morooka S, Suda K, et al. Retinal blood flow velocity change in Parafoveal capillary after topical Tafluprost treatment in eyes with primary open-angle glaucoma. Sci Rep. 2017;7(1):5019.PubMedPubMedCentralCrossRef
10.
11.
Mansouri K. Optical coherence tomography angiography and glaucoma: searching for the missing link. Expert Rev Med Devices. 2016;13(10):879–80.PubMedCrossRef
12.
Chen HS, Liu CH, Wu WC, Tseng HJ, Lee YS. Optical coherence tomography angiography of the superficial microvasculature in the macular and Peripapillary areas in glaucomatous and healthy eyes. Invest Ophthalmol Vis Sci. 2017;58(9):3637–45.PubMedCrossRef
13.
Mansoori T, Gamalapati J, Sivaswamy J, Balakrishna N. Optical coherence tomography angiography measured capillary density in the normal and glaucoma eyes. Saudi J Ophthalmol. 2018;32(4):295–302.PubMedPubMedCentralCrossRef
14.
Lommatzsch C, Rothaus K, Koch JM, Heinz C, Grisanti S. Vessel density in OCT angiography permits differentiation between normal and glaucomatous optic nerve heads. Int J Ophthalmol. 2018;11(5):835–43.PubMedPubMedCentral
15.
Shoji T, Zangwill LM, Akagi T, Saunders LJ, Yarmohammadi A, Manalastas PIC, et al. Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study. Am J Ophthalmol. 2017;182:107–17.PubMedPubMedCentralCrossRef
16.
17.
18.
Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012;7(4):e34823.PubMedPubMedCentralCrossRef
19.
Sidak Z. Rectangular confidence regions for the means of multivariate Normal distributions. J Am Stat Assoc. 1967;62(318):626–33.
20.
Takagi Y, Nakajima T, Shimazaki A, Kageyama M, Matsugi T, Matsumura Y, et al. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res. 2004;78(4):767–76.PubMedCrossRef
21.
Ota T, Murata H, Sugimoto E, Aihara M, Araie M. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Invest Ophthalmol Vis Sci. 2005;46(6):2006–11.PubMedCrossRef
22.
Konstas AG, Boboridis KG, Kapis P, Marinopoulos K, Voudouragkaki IC, Panayiotou D, et al. 24-hour efficacy and ocular surface health with preservative-free Tafluprost alone and in conjunction with preservative-free Dorzolamide/Timolol fixed combination in open-angle glaucoma patients insufficiently controlled with preserved Latanoprost Monotherapy. Adv Ther. 2017;34(1):221–35.PubMedCrossRef
23.
Traverso CE, Ropo A, Papadia M, Uusitalo H. A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost. J Ocul Pharmacol Ther. 2010;26(1):97–104.PubMedCrossRef
24.
Sutton A, Gilvarry A, Ropo A. A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males. J Ocul Pharmacol Ther. 2007;23(4):359–65.PubMedCrossRef
25.
Dong Y, Watabe H, Su G, Ishikawa H, Sato N, Yoshitomi T. Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries. Exp Eye Res. 2008;87(3):251–6.PubMedCrossRef
26.
Tsuda S, Yokoyama Y, Chiba N, Aizawa N, Shiga Y, Yasuda M, et al. Effect of topical tafluprost on optic nerve head blood flow in patients with myopic disc type. J Glaucoma. 2013;22(5):398–403.PubMedCrossRef
27.
Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21(4):359–93.PubMedCrossRef
28.
29.
Wylegala A, Teper S, Dobrowolski D, Wylegala E. Optical coherence angiography: a review. Medicine (Baltimore). 2016;95(41):e4907.CrossRef
30.
Leveque PM, Zeboulon P, Brasnu E, Baudouin C, Labbe A. Optic disc vascularization in glaucoma: value of spectral-domain optical coherence tomography angiography. J Ophthalmol. 2016;2016:6956717.PubMedPubMedCentral
31.
Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Manalastas PI, Fatehee N, et al. Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes. Invest Ophthalmol Vis Sci. 2016;57(9):OCT451–9.PubMedPubMedCentralCrossRef
32.
Mansoori T, Sivaswamy J, Gamalapati JS, Balakrishna N. Radial Peripapillary capillary density measurement using optical coherence tomography angiography in early glaucoma. J Glaucoma. 2017;26(5):438–43.PubMedCrossRef
33.
Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Yousefi S, Saunders LJ, et al. Relationship between optical coherence tomography angiography vessel density and severity of visual field loss in glaucoma. Ophthalmology. 2016;123(12):2498–508.PubMedCrossRef
34.
Rabiolo A, Gelormini F, Sacconi R, Cicinelli MV, Triolo G, Bettin P, et al. Comparison of methods to quantify macular and peripapillary vessel density in optical coherence tomography angiography. PLoS One. 2018;13(10):e0205773.PubMedPubMedCentralCrossRef
35.
Manalastas PIC, Zangwill LM, Saunders LJ, Mansouri K, Belghith A, Suh MH, et al. Reproducibility of optical coherence tomography angiography macular and optic nerve head vascular density in glaucoma and healthy eyes. J Glaucoma. 2017;26(10):851–9.PubMedPubMedCentralCrossRef
36.
Liu L, Jia Y, Takusagawa HL, Pechauer AD, Edmunds B, Lombardi L, et al. Optical coherence tomography angiography of the Peripapillary retina in glaucoma. JAMA Ophthalmol. 2015;133(9):1045–52.PubMedPubMedCentralCrossRef
37.
Jia Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014;121(7):1322–32.PubMedCrossRef
38.
Alnawaiseh M, Lahme L, Muller V, Rosentreter A, Eter N. Correlation of flow density, as measured using optical coherence tomography angiography, with structural and functional parameters in glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2018;256(3):589–97.PubMedCrossRef
39.
Penteado RC, Zangwill LM, Daga FB, Saunders LJ, Manalastas PIC, Shoji T, et al. Optical coherence tomography angiography macular vascular density measurements and the central 10-2 visual field in glaucoma. J Glaucoma. 2018;27(6):481–9.PubMedPubMedCentralCrossRef
40.
Wan KH, Lam AKN, Leung CK. Optical coherence tomography angiography compared with optical coherence tomography macular measurements for detection of glaucoma. JAMA Ophthalmol. 2018;136(8):866–74.PubMedPubMedCentralCrossRef
41.
Kromer R, Glusa P, Framme C, Pielen A, Junker B. Optical coherence tomography angiography analysis of macular flow density in glaucoma. Acta Ophthalmol. 2019;97(2):e199–206.PubMedCrossRef
42.
Moghimi S, Zangwill LM, Penteado RC, Hasenstab K, Ghahari E, Hou H, et al. Macular and optic nerve head vessel density and progressive retinal nerve fiber layer loss in glaucoma. Ophthalmology. 2018;125(11):1720–8.PubMedCrossRef
43.
In JH, Lee SY, Cho SH, Hong YJ. Peripapillary vessel density reversal after trabeculectomy in glaucoma. J Ophthalmol. 2018;2018:8909714.PubMedPubMedCentral
44.
Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66–100.PubMedPubMedCentralCrossRef
45.
Alnawaiseh M, Muller V, Lahme L, Merte RL, Eter N. Changes in flow density measured using optical coherence tomography angiography after iStent insertion in combination with phacoemulsification in patients with open-angle glaucoma. J Ophthalmol. 2018;2018:2890357.PubMedPubMedCentral
46.
Hollo G. Influence of large intraocular pressure reduction on Peripapillary OCT vessel density in ocular hypertensive and glaucoma eyes. J Glaucoma. 2017;26(1):e7–e10.PubMedCrossRef
47.
Brucher VC, Storp JJ, Eter N, Alnawaiseh M. Optical coherence tomography angiography-derived flow density: a review of the influencing factors. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):701–10.PubMedCrossRef
48.
Geyman LS, Garg RA, Suwan Y, Trivedi V, Krawitz BD, Mo S, et al. Peripapillary perfused capillary density in primary open-angle glaucoma across disease stage: an optical coherence tomography angiography study. Br J Ophthalmol. 2017;101(9):1261–8.PubMedCrossRef
Metadata
Title
OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy
Authors
Hannah Weindler
Martin S. Spitzer
Maximilian Schultheiß
Robert Kromer
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01707-3

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue

Case report

Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report

Research article

Comparison of refractive outcomes after photorefractive keratectomy with different optical zones using Mel 90 excimer laser

Research article

Evaluation of enhanced external counterpulsation therapy for nonarteritic anterior ischemic optic neuropathy

Case report

CT and MRI findings in relapsing primary malignant melanoma of the lacrimal sac: a case report and brief literature review

Case report

A case report of fulminant endophthalmitis caused by Streptococcus dysgalactiae in a patient with traumatic corneal laceration

Research article

Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy